|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kankeu Fonkoua L and Yee NS: Molecular
characterization of gastric carcinoma: Therapeutic implications for
biomarkers and targets. Biomedicines. 6:E322018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Itoga S, Harada S and Nomura F:
Polymorphism of the 5′-flanking region of the CYP2E1 gene: An
association study with alcoholism. Alcohol Clin Exp Res. 25 (Suppl
6):S11–S55. 2006. View Article : Google Scholar
|
|
4
|
Kaibara N, Kobori A, Sekime A and Miyasaka
K: The menstrual cycle influences the gastric emptying of alcohol.
Biomed Res. 36:411–415. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu H, Jia Z, Misra H and Li YR: Oxidative
stress and redox signaling mechanisms of alcoholic liver disease:
Updated experimental and clinical evidence. J Dig Dis. 13:133–142.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin M, Kumar A, Kumar S and Srivastava RK:
Ethanol-mediated regulation of cytochrome P450 2A6 expression in
monocytes: Role of oxidative stress-mediated PKC/MEK/Nrf2 pathway.
PLoS One. 7:e355052012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ortega Ugalde S, Boot M, Commandeur JNM,
Jennings P, Bitter W and Vos JC: Function, essentiality, and
expression of cytochrome P450 enzymes and their cognate redox
partners in Mycobacterium tuberculosis: Are they drug targets? Appl
Microbiol Biotechnol. 103:3597–3614. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qu R, Li X, Quan X, Xia L, Fang X, Li H
and Zhou B: Polymorphism in CYP24A1 is associated with lung cancer
risk: A case-control study in Chinese female nonsmokers. DNA Cell
Biol. 38:243–249. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kato S, Naito Z, Matsuda N, Onodera H,
Sakurazawa N, Yamashita N, Kanazawa Y, Fujita I, Makino H and
Uchida E: Localization of cytochrome P4502E1 enzyme in normal and
cancerous gastric mucosa and association with its genetic
polymorphism in unoperated and remnant stomach. J Nippon Med Sch.
78:224–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ho JC, Cheung ST, Leung KL, Ng IO and Fan
ST: Decreased expression of cytochrome P450 2E1 is associated with
poor prognosis of hepatocellular carcinoma. Int J Cancer.
111:494–500. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao J, Wang GJ, Wang Z, Gao N, Li J, Zhang
YF, Zhou J, Zhang HX, Wen Q, Jin H and Qiao HL: High CYP2E1
activity correlates with hepatofibrogenesis induced by
nitrosamines. Oncotarget. 8:112199–112210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zeng T, Zhang CL, Zhao N, Guan MJ, Xiao M,
Yang R, Zhao XL, Yu LH, Zhu ZP and Xie KQ: Impairment of Akt
activity by CYP2E1 mediated oxidative stress is involved in chronic
ethanol-induced fatty liver. Redox Biol. 14:295–304. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hernando-Rodriguez M, Rey-Barja N,
Marichalar-Mendia X, Rodriguez-Tojo MJ, Acha-Sagredo A and
Aguirre-Urizar JM: Role of cytochrome P-450 genetic polymorphisms
in oral carcinogenesis. J Oral Pathol Med. 41:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koyuncu I, Gonel A, Durgun M, Kocyigit A,
Yuksekdag O and Supuran CT: Assessment of the antiproliferative and
apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in
HeLa cancer cell line. J Enzyme Inhib Med Chem. 34:75–86. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tian X, Ji Y, Liang Y, Zhang J, Guan L and
Wang C: LINC00520 targeting miR-27b-3p regulates OSMR expression
level to promote acute kidney injury development through the
PI3K/AKT signaling pathway. J Cell Physiol. 234:14221–14233. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen H, Zhang J, Zhang Y, Feng Q, Wang H,
Li G, Jiang W and Li X: Knockdown of tripartite motif 59 (TRIM59)
inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR
signalling pathway. Gene. 698:50–60. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xing Y, Ren S, Ai L, Sun W, Zhao Z, Jiang
F, Zhu Y and Piao D: ZNF692 promotes colon adenocarcinoma cell
growth and metastasis by activating the PI3K/AKT pathway. Int J
Oncol. 54:1691–1703. 2019.PubMed/NCBI
|
|
19
|
Slattery ML, Mullany LE, Sakoda LC, Wolff
RK, Stevens JR, Samowitz WS and Herrick JS: The PI3K/AKT signaling
pathway: Associations of miRNAs with dysregulated gene expression
in colorectal cancer. Mol Carcinog. 57:243–261. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sivalingam K, Amirthalingam V, Ganasan K,
Huang CY and Viswanadha VP: Neferine suppresses
diethylnitrosamine-induced lung carcinogenesis in Wistar rats. Food
Chem Toxicol. 123:385–398. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Potočnjak I and Domitrović R: Carvacrol
attenuates acute kidney injury induced by cisplatin through
suppression of ERK and PI3K/Akt activation. Food Chem Toxicol.
98:251–261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leung T, Rajendran R, Singh S, Garva R,
Krstic-Demonacos M and Demonacos C: Cytochrome P450 2E1 (CYP2E1)
regulates the response to oxidative stress and migration of breast
cancer cells. Breast Cancer Res. 15:R1072013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao J, Zhou J, He XP, Zhang YF, Gao N,
Tian X, Fang Y, Wen Q, Jia LJ, Jin H and Qiao HL: Changes in
cytochrome P450s-mediated drug clearance in patients with
hepatocellular carcinoma in vitro and in vivo: A bottom-up
approach. Oncotarget. 7:28612–28623. 2016.PubMed/NCBI
|
|
24
|
Tonack S, Patel S, Jalali M, Nedjadi T,
Jenkins RE, Goldring C, Neoptolemos J and Costello E:
Tetracycline-inducible protein expression in pancreatic cancer
cells: Effects of CapG overexpression. World J Gastroenterol.
17:1947–1960. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Na HK and Lee JY: Molecular basis of
alcohol-related gastric and colon cancer. Int J Mol Sci.
18:E11162017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ratna A and Mandrekar P: Alcohol and
cancer: Mechanisms and therapies. Biomolecules. 7:E612017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kamalipour S, Barzegar A, Shokrzadeh M and
Nikbakhsh N: Increased Expression of CYP2E1 gene in gastric cancer
may be a molecular marker for mazandaran province population. J
Genet Resources. 2:130–136. 2017.
|
|
28
|
Tan W, Wu J, Tang H and Lin D: Expression
of cytochrome P4502E1 in human liver: Relationship between genotype
and phenotype in Chinese. Sci China Series C, Life Sci. 44:356–364.
2001. View Article : Google Scholar
|
|
29
|
Song L, Zhou Z, Gan Y, Li P, Xu Y, Zhang
Z, Luo F, Xu J, Zhou Q and Dai F: Long noncoding RNA OIP5-AS1
causes cisplatin resistance in osteosarcoma through inducing the
LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
J Cell Biochem. 120:9656–9666. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vaclavikova R, Hubackova M,
Stribrna-Sarmanova J, Kodet R, Mrhalova M, Novotny J, Gut I and
Soucek P: RNA expression of cytochrome P450 in breast cancer
patients. Anticancer Res. 27:4443–4450. 2007.PubMed/NCBI
|
|
31
|
Schattenberg JM, Wang Y, Rigoli RM, Koop
DR and Czaja MJ: CYP2E1 overexpression alters hepatocyte death from
menadione and fatty acids by activation of ERK1/2 signaling.
Hepatology. 39:444–455. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Abboud-Jarrous G, Aingorn H, Ranginiguetta
Z, Atzmon R, Zcharia E, Peretz T and Vlodavsky I: Heparanase
processing: Site directed mutagenesis, proteolytic cleavage and
activation. Cell Mol Biol. 65:2005.
|
|
33
|
Xie B, Wu G, Chen P, Liu K and Yuan T:
Mechanism and clinical significance of HBx-mediated inhibition of
CYP2E1 expression in the human HepG2 hepatoma cell line. Zhonghua
Gan Zang Bing Za Zhi. 22:122–127. 2014.(In Chinese). PubMed/NCBI
|
|
34
|
Flores-Bellver M, Bonet-Ponce L, Barcia
JM, Garcia-Verdugo JM, Martinez-Gil N, Saez-Atienzar S,
Sancho-Pelluz J, Jordan J, Galindo MF and Romero FJ: Autophagy and
mitochondrial alterations in human retinal pigment epithelial cells
induced by ethanol: Implications of 4-hydroxy-nonenal. Cell Death
Dis. 5:e13282014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
García-Carracedo D, Villaronga MÁ,
Álvarez-Teijeiro S, Hermida- Prado F and García-Pedrero JM: Impact
of PI3K/AKT/mTOR pathway activation on the prognosis of patients
with head and neck squamous cell carcinomas. Oncotarget.
7:29780–29793. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Faes S, Santoro T, Troquier L, De Souza
Silva O and Dormond O: Rebound pathway overactivation by cancer
cells following discontinuation of PI3K or mTOR inhibition promotes
cancer cell growth. Biochem Biophys Res Commun. 513:546–552. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang X, Li W, Williams M, Terada N, Alessi
DR and Proud CG: Regulation of elongation factor 2 kinase by
p90(RSK1) and p70 S6 kinase. EMBO J. 20:4370–4379. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gang Z, Huikai L, Tao S and Nan Z: CSN5
silencing inhibits invasion and arrests cell cycle progression in
human colorectal cancer SW480 and LS174T cells in vitro. Int J Clin
Exp Pathol. 8:2809–2815. 2015.PubMed/NCBI
|
|
39
|
Wee KB and Aguda BD: Akt versus p53 in a
network of oncogenes and tumor suppressor genes regulating cell
survival and death. Biophys J. 91:857–865. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang HY, Xue LY, Xing LX, Wang J, Wang JL,
Yan X and Zhang XH: Putative role of the mTOR/4E-BP1 signaling
pathway in the carcinogenesis and progression of gastric cardiac
adenocarcinoma. Mol Med Rep. 7:537–542. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kozma SC and Thomas G: Regulation of cell
size in growth, development and human disease: PI3K, PKB and S6K.
Bioessays. 24:65–71. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Homann N: Alcohol and upper
gastrointestinal tract cancer: The role of local acetaldehyde
production. Addict Biol. 6:309–323. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ma XM, Yoon SO, Richardson CJ, Julich K
and Blenis J: SKAR links pre-mRNA splicing to mTOR/S6K1-mediated
enhanced translation efficiency of spliced mRNAs. Cell.
133:303–313. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gogtay NJ, Kapileshwar SR, Shah SU,
Bendkhale SR, Ramakrishna S, Sridharan K, Thelma BK, Thatte UM and
Kshirsagar NA: Evaluation of cytochrome P4502E1 polymorphisms in
healthy adult Western Indians and patients with antituberculous
drug-induced hepatotoxicity. Indian J Pharmacol. 48:42–46. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Takac T, Pechan T, Samajova O and Samaj J:
Vesicular trafficking and stress response coupled to PI3K
inhibition by LY294002 as revealed by proteomic and cell biological
analysis. J Proteome Res. 12:4435–4448. 2013. View Article : Google Scholar : PubMed/NCBI
|
